Stepan/$SCL
1D1W1MYTD1Y5YMAX
Capital at risk
About Stepan
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
- Ticker
- $SCL
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 2,328
- Headquarters
- Northbrook, United States
- Website
- www.stepan.com
Stepan Metrics
BasicAdvanced
$1.4B
-
-$0.12
0.94
$1.58
2.51%
Price and volume
Market cap
$1.4B
Beta
0.94
52-week high
$68.00
52-week low
$41.82
Average daily volume
120K
Dividend rate
$1.58
Financial strength
Current ratio
1.151
Quick ratio
0.715
Long term debt to equity
0.201
Total debt to equity
0.465
Interest coverage (TTM)
2.95%
Profitability
EBITDA (TTM)
209.637
Gross margin (TTM)
11.81%
Net profit margin (TTM)
-0.11%
Operating margin (TTM)
3.32%
Effective tax rate (TTM)
-445.68%
Revenue per employee (TTM)
$1,050,000
Management effectiveness
Return on assets (TTM)
2.10%
Return on equity (TTM)
-0.22%
Valuation
Price to revenue (TTM)
0.591
Price to book
1.19
Price to tangible book (TTM)
1.19
Price to free cash flow (TTM)
39.33
Free cash flow yield (TTM)
2.54%
Free cash flow per share (TTM)
1.599
Dividend yield (TTM)
2.51%
Forward dividend yield
2.51%
Growth
Revenue change (TTM)
7.63%
Earnings per share change (TTM)
-104.72%
3-year revenue growth (CAGR)
-1.91%
10-year revenue growth (CAGR)
3.27%
3-year earnings per share growth (CAGR)
-67.33%
10-year earnings per share growth (CAGR)
-29.78%
3-year dividend per share growth (CAGR)
3.16%
10-year dividend per share growth (CAGR)
7.67%
What the Analysts think about Stepan
Analyst ratings (Buy, Hold, Sell) for Stepan stock.
Analyst projections of the future price of Stepan stock.
Bulls say / Bears say
Adjusted EBITDA jumped 45% YoY to $74.4 million in Q2 2026, reflecting strong margin recovery and sales volume growth in the surfactants and polymers segments (SEC).
Organic sales volume rose 6% YoY in Q2 2026, propelled by growth in Tier 2/3 surfactants and North American polymers (SEC).
The Board approved a plan under Project Catalyst to reduce approximately 100 global salaried roles in Q3 2026, underscoring Stepan’s commitment to operational efficiency and cost savings (SEC).
Free cash flow was negative $15.0 million in Q2 2026 due to elevated working capital requirements, which may pressure liquidity and funding flexibility (SEC).
Adjusted EBITDA for the Specialty Products segment declined in Q2 2026 due to an unfavorable product mix in medium chain triglycerides, highlighting margin vulnerability (PR Newswire).
Stepan incurred a $5.1 million restructuring charge in Q2 2026 related to the closure of its Fieldsboro, NJ site and decommissioning of assets, signalling ongoing operational disruptions (SEC).
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.
Stepan Financial Performance
Revenues and expenses
Stepan Earnings Performance
Company profitability
Upcoming events
No upcoming events
Stepan News
AllArticlesVideos
Funds containing Stepan
AllUSDGBPEUR
Fund name | Fund size | $SCL weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.08% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.08% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.05% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.